TG and myocardial infarction: Nevertheless, as shown in Figure 1, the steep increases in Tg levels observed prior to the introduction of LVB, during the period when sorafenib was administered instead, and during the interruption following myocardial infarction and peritonitis were clearly mitigated, though not completely suppressed, by LVB therapy.